Multiple types of mutations and changes in expression in HOXD11 have been observed in lung cancer, Oral Squamous Cell Carcinoma, prostate cancer, ovarian cancer, and Head and Neck Squamous Cell Carcinoma. This evidence concerns the gene HOXD11 and ovarian carcinoma.